370 related articles for article (PubMed ID: 23598816)
21. Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease.
Zhong W; Kolls JK; Chen H; McAllister F; Oliver PD; Zhang Z
Front Biosci; 2008 Jan; 13():1654-64. PubMed ID: 17981657
[TBL] [Abstract][Full Text] [Related]
22. The role of physical exercise in inflammatory bowel disease.
Bilski J; Brzozowski B; Mazur-Bialy A; Sliwowski Z; Brzozowski T
Biomed Res Int; 2014; 2014():429031. PubMed ID: 24877092
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.
Sukocheva OA; Lukina E; McGowan E; Bishayee A
Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881
[TBL] [Abstract][Full Text] [Related]
24. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration.
Cesaro A; Brest P; Hofman V; Hébuterne X; Wildman S; Ferrua B; Marchetti S; Doglio A; Vouret-Craviari V; Galland F; Naquet P; Mograbi B; Unwin R; Hofman P
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G32-42. PubMed ID: 20185692
[TBL] [Abstract][Full Text] [Related]
25. Progressing from Recurring Tissue Injury to Genomic Instability: A New Mechanism of Neutrophil Pathogenesis.
Bui TM; Sumagin R
DNA Cell Biol; 2019 Aug; 38(8):747-753. PubMed ID: 31188020
[TBL] [Abstract][Full Text] [Related]
26. Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease.
Larmonier CB; Midura-Kiela MT; Ramalingam R; Laubitz D; Janikashvili N; Larmonier N; Ghishan FK; Kiela PR
Inflamm Bowel Dis; 2011 Feb; 17(2):503-15. PubMed ID: 20629184
[TBL] [Abstract][Full Text] [Related]
27. Activation of TGF-
Liu Z; Kong F; Vallance JE; Harmel-Laws E; Amarachintha S; Steinbrecher KA; Rosen MJ; Bhattacharyya S
Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28373409
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients.
Bouzid D; Gargouri B; Mansour RB; Amouri A; Tahri N; Lassoued S; Masmoudi H
Saudi J Gastroenterol; 2013; 19(3):131-5. PubMed ID: 23680711
[TBL] [Abstract][Full Text] [Related]
29. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.
Butin-Israeli V; Bui TM; Wiesolek HL; Mascarenhas L; Lee JJ; Mehl LC; Knutson KR; Adam SA; Goldman RD; Beyder A; Wiesmuller L; Hanauer SB; Sumagin R
J Clin Invest; 2019 Feb; 129(2):712-726. PubMed ID: 30640176
[TBL] [Abstract][Full Text] [Related]
31. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.
Saiz-Gonzalo G; Hanrahan N; Rossini V; Singh R; Ahern M; Kelleher M; Hill S; O'Sullivan R; Fanning A; Walsh PT; Hussey S; Shanahan F; Nally K; O'Driscoll CM; Melgar S
Front Immunol; 2021; 12():655960. PubMed ID: 34394073
[TBL] [Abstract][Full Text] [Related]
32. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease.
Ina K; Kusugami K; Hosokawa T; Imada A; Shimizu T; Yamaguchi T; Ohsuga M; Kyokane K; Sakai T; Nishio Y; Yokoyama Y; Ando T
J Gastroenterol Hepatol; 1999 Jan; 14(1):46-53. PubMed ID: 10029277
[TBL] [Abstract][Full Text] [Related]
33. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
Lira-Junior R; Figueredo CM
World J Gastroenterol; 2016 Sep; 22(35):7963-72. PubMed ID: 27672291
[TBL] [Abstract][Full Text] [Related]
34. Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-
Haring E; Zeiser R; Apostolova P
Front Immunol; 2021; 12():705342. PubMed ID: 34249014
[TBL] [Abstract][Full Text] [Related]
35. The vasculitis in IBD is associated with the degree of inflammation.
Kruschewski M; Buhr HJ
Dig Dis Sci; 2010 Mar; 55(3):733-8. PubMed ID: 19267197
[TBL] [Abstract][Full Text] [Related]
36. Investigating intestinal inflammation in DSS-induced model of IBD.
Kim JJ; Shajib MS; Manocha MM; Khan WI
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22331082
[TBL] [Abstract][Full Text] [Related]
37. Targeting of Neutrophil Lewis X Blocks Transepithelial Migration and Increases Phagocytosis and Degranulation.
Brazil JC; Sumagin R; Cummings RD; Louis NA; Parkos CA
Am J Pathol; 2016 Feb; 186(2):297-311. PubMed ID: 26687991
[TBL] [Abstract][Full Text] [Related]
38. Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease.
Chami B; Martin NJJ; Dennis JM; Witting PK
Arch Biochem Biophys; 2018 May; 645():61-71. PubMed ID: 29548776
[TBL] [Abstract][Full Text] [Related]
39. The microbiota and inflammatory bowel disease: insights from animal models.
Peloquin JM; Nguyen DD
Anaerobe; 2013 Dec; 24():102-6. PubMed ID: 23603043
[TBL] [Abstract][Full Text] [Related]
40. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.
Bilski J; Mazur-Bialy A; Wojcik D; Surmiak M; Magierowski M; Sliwowski Z; Pajdo R; Kwiecien S; Danielak A; Ptak-Belowska A; Brzozowski T
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
